Recently, an association was reported between a form of hemolytic-uremic syndrome and the use of adjuvant chemotherapy with mitomycin C and 5-fluorouracil. Our report presents the clinical course of a patient with this syndrome along with detailed renal pathological studies (including electron and immunofluorescence microscopy). This information is not available for most previous reports.
Willie, Glen R.; Levy, Stanley M.; Michaels, Robert S.; and Zirkin, Richard M.
"Hemolytic-Uremic Syndrome in a Patient Receiving Mitomycin C and 5-Fluorouracil,"
Henry Ford Hospital Medical Journal
: Vol. 31
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol31/iss2/9